Safety issues with transdermal opioid medications - Australian and ...

More documents

Recommendations

Info

New South Wales IIMS data 2 - Type of notification NSW IIMS Transdermal medication issues ( all meds) July 06 to June 07 350 100 300 250 80 Frequency 200 150 60 40 Percent 100 50 20 0 Issue Admin Presc Other S8 issues Disp Frequency 197 67 43 19 4 Percent 59.7 20.3 13.0 5.8 1.2 Cum % 59.7 80.0 93.0 98.8 100.0 0
Perceived problems with patches Perceived problems with patches Pareto Chart of Voting on Issues of Transdermal Medications Vote Percent Medication chart needs On and O ff charted Patch es no t visible designed to be discreet No process for documenting patch location Education of Doctors Staff working too fast. Put o n & no t remove Patient education Other Issue 40 30 20 10 0 100 80 60 40 20 0 Count 7 7 6 4 4 3 6 Percent 18.9 18.9 16.2 10.8 10.8 8.1 16.2 Cum % 18.9 37.8 54.1 64.9 75.7 83.8 100.0
Page 1 and 2: Safety issues with transdermal opio
Page 3 and 4: An example • Patient arrived in E
Page 5 and 6: Cross section of a Norspan transder
Page 7 and 8: New South Wales IIMS data 1. - Medi
Page 9 and 10: Well, this doesn’t t appear to be
Page 11: And again - a common notification
Page 15 and 16: And the culprits are? 100 95 Notifi
Page 17 and 18: 100 80 Percent 60 Buprenorphine Bup
Page 19 and 20: Did the Alert make a difference?
Page 21 and 22: Warnings at Home
Page 23 and 24: MIMS Prescribing information also c
Page 25 and 26: What can you do as pain specialists
Page 27 and 28: All about communication - 2

Safety issues with transdermal opioid medications - Australian and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?